Marker Therapeutics, Inc.
MRKR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,731 | -$14,046 | -$19,776 | -$41,879 |
| Dep. & Amort. | $0 | $0 | $0 | $3,163 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $246 | $858 | $0 | $5,964 |
| Change in WC | -$425 | $2,847 | -$4,764 | $5,472 |
| Other Non-Cash | $0 | -$6,099 | -$2,433 | $0 |
| Operating Cash Flow | -$10,910 | -$16,440 | -$26,972 | -$27,280 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$3,131 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $18,664 | -$4,945 | $0 |
| Investing Cash Flow | $0 | $18,664 | -$4,945 | -$3,131 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $14,929 | $1,015 | $202 | $52,553 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $62 | $90 | $0 | $3 |
| Financing Cash Flow | $14,991 | $1,105 | $202 | $52,556 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,081 | $3,329 | -$31,715 | $22,145 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,111 | $11,782 | $43,497 | $21,352 |
| End Cash | $19,192 | $15,111 | $11,782 | $43,497 |
| Free Cash Flow | -$10,910 | -$16,440 | -$26,972 | -$30,411 |